Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SPRINT.ST Forward P/E

The Forward P/E of Sprint Bioscience AB (SPRINT.ST) is 1.17.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

SPRINT.ST Forward P/E - Peers Comparison